Asset Details
Do you wish to reserve the book?
Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
Do you wish to request the book?
Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer
2018
Overview
Background
Calprotectin (S100A8/S100A9), a heterodimeric EF-hand Ca
2+
binding protein, are abundant in cytosol of neutrophils and are involved in inflammatory processes and several cancerous pathogens.
Objective
The purpose of the present systematic review is to evaluate the pro- and anti-tumorigenic functions of calprotectin and its relation to inflammation.
Materials and methods
We conducted a review of studies published in the Medline (1966–2018), Scopus (2004–2018), ClinicalTrials.gov (2008–2018) and Google Scholar (2004–2018) databases, combined with studies found in the reference lists of the included studies.
Results
Elevated levels of S100A8/S100A9 were detected in inflammation, neoplastic tumor cells and various human cancers. Recent data have explained that many cancers arise from sites of infection, chronic irritation, and inflammation. The inflammatory microenvironment which largely includes calprotectin, has an essential role on high producing of inflammatory factors and then on neoplastic process and metastasis.
Conclusion
Scientists have shown different outcomes in inflammation, malignancy and apoptosis whether the source of the aforementioned protein is extracellular or intracellular. These findings are offering new insights that anti-inflammatory therapeutic agents and anti-tumorigenic functions of calprotectin can lead to control cancer development.
Publisher
Springer International Publishing,Springer Nature B.V
